The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo. (17/25)

Do anti-angiogenic or angiogenic factors contribute to the protection of birth weight at high altitude afforded by Andean ancestry? (18/25)

Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. (19/25)

Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. (20/25)

Endorepellin, the angiostatic module of perlecan, interacts with both the alpha2beta1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. (21/25)

Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. (22/25)

Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis. (23/25)

Anti-angiogenic treatment strategies for the therapy of endometriosis. (24/25)

• 1
• 2
• 3
• 4